6533b82bfe1ef96bd128d405

RESEARCH PRODUCT

Combination of the novel farnesyltransferase inhibitor RPR 130401 and the gerannylgeranyltransferase-1 inhibitor GGTI-298 disrupts MAP kinase activation and G1-S transition in Ki-Ras-overexpressing transformed adrenocortical cells

J.l. MazetM. PadieuH. OsmanG. MaumeP. MaillietN. DereuA.d. HamiltonF. LavelleS.m. SebtiB.f. Maume

subject

RAT[SDV.BC]Life Sciences [q-bio]/Cellular BiologyTECHNIQUE DES TRACEURS[SDV.BC] Life Sciences [q-bio]/Cellular BiologyCANCERComputingMilieux_MISCELLANEOUS

description

International audience

https://hal.inrae.fr/hal-02694628